Innovation
expressTEC
1st RNA-based test for targeted treatment eligibility. expressPIK makes the right choice of treatment a reality.
expressTEC
1st RNA-based test for targeted treatment eligibility. expressPIK makes the right choice of treatment a reality.
Our Product
As pioneers in the field, we proudly offer the first RNA-based test for targeted treatment eligibility. By harnessing the power of RNA analysis, we provide a comprehensive understanding of a patient's tumour genetic profile, enabling healthcare providers make informed decisions about tailored treatment options.
RNA tests are fast and have unwavering accuracy.
Affordable price for hospitals and clinical labs.
Harnessing the power of RNA-based testing to guide personalized treatment decisions.
Patients are being misguided for Treatment.
expressTEC, the 1st RNA-based test, will contribute to advancements in precision medicine positively impacting the lives of breast cancer patients worldwide.
Accurate, Easy and Fast to implement.
Our mission is to empower healthcare professionals with fast and reliable tools that identify the most suitable patients for treatment, ensuring optimal therapeutic efficacy while minimising side effects.
Winner of the 'Altice International Innovation Award 2023'
This technology allows "signing the personalisation of a therapy". The recognition, in turn, represents an "opportunity to learn to develop the business side and the transfer of technology, something that scientists are little used to".
We have 30+ years of experience in Cancer Research.
Both co-founders are experienced researchers in human and cancer genetics, particularly in
breast cancer genomics. Both have a successful past in securing research funding and leading
teams.
Our Team
Our team boasts a remarkable blend of diverse talents, seamlessly integrating scientific expertise with business acumen. We foster a dynamic, multidimensional approach that fuels innovation and drives transformative results.
CEO&CSO
CTO
About expressTEC
The project has garnered recognition and validation from experts. These endorsements highlight the project's quality and positive impact on the professional community, solidifying its credibility and success.
Support us and start to promote this idea.
We want to contribute to impacting the lives of breast cancer patients worldwide.
Latest News
Stay up to date with the main news about the project expressTEC
The start-up expressTEC, led by Ana Teresa Maia and Joana Xavier, is the winner of the Altice International Innovation Award
A team of researchers from the Health Technologies and Services Research Centre (CINTESIS), representing the University of Algarve, has just
ExpressTEC, a spin-off incubated at the University of Algarve, was one of seven Portuguese technology-based companies led by women selected
BfK INNOV@Rise Alentejo presents the finalist projects of the program developed by the National Innovation Agency (ANI). Solutions for aviation,
If you're keen to collaborate with us...
expressTEC is currently looking for partner institutions (Hospitals and Clinical labs) to conduct Clinical Trials for the products in its pipeline. Please contact us if your institution wants to know more about this opportunity.
